We are live on
!
Find out more
C
Cerebellum Portfolio holdings
AUM
$21.5M
This Fund
S&P 500
This Quarter
Est. Return
+28.03%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$141M
AUM Growth
–
Cap. Flow
+$107M
Cap. Flow
% of AUM
75.56%
Top 10 Holdings %
Top 10 Hldgs %
24.49%
Holding
471
New
471
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$3.76M |
| 2 |
Popular Inc
BPOP
|
+$3.5M |
| 3 |
SCG
Scana
SCG
|
+$3.44M |
| 4 |
ARRS
ARRIS International plc Ordinary Shares
ARRS
|
+$3.44M |
| 5 |
S
Sprint Corporation
S
|
+$3.38M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 20.84% |
| 2 | Financials | 17.06% |
| 3 | Healthcare | 9.62% |
| 4 | Industrials | 9.61% |
| 5 | Consumer Discretionary | 9.51% |
Similar funds
PCM
JJ
BPI
TCS
AF
SC
IAM
MTB
Cerebellum's Q2 2020 Portfolio in Review
Q2 2020 is the first quarter with a 13F filing on record for Cerebellum, which disclosed 471 positions worth $141M. Its ten largest holdings account for 24% of the portfolio.
Its largest position is Allergan plc: 20,256 shares worth $3.31M.
By sector, the portfolio is most concentrated in Energy at 21% of assets, followed by Financials and Healthcare.
- Cerebellum's largest Q2 2020 buy was Allergan plc: 20,256 shares worth $3.31M.
- Cerebellum's ten largest holdings make up 24% of its $141M portfolio in Q2 2020.
- Cerebellum disclosed 471 positions in Q2 2020, its first 13F filing on record.
Based on Cerebellum's 13F filing for Q2 2020, filed 22 Jul 2020.